Corroborating further the idea that a combination of MDK and AFP increases diagnostic capacity for HCC, Mashaly et al. [48] also evaluated serum MDK levels by ELISA in 44 HCC patients, 31 with liver cirrhosis, and 15 healthy controls. This evidence concerns the gene MDK and hepatocellular carcinoma.